External Research Grants for U.S. Investigators

Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) - BI Cares Foundation


Grant amount: Up to US $1,000,000

Deadline: Rolling

Applicant type: Research Scientist Doctor Postdoctoral Researcher Faculty

Funding uses: Biomedical

Location of project: United States

Location of residency: United States

View website    Save Need help writing this grant?

Overview:

External Research Grants

The mission of the Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) External Research Grants Program for U.S. Investigators is to support the advancement of scientific knowledge regarding BIPI products and therapeutic areas of interest, through support of novel research proposals in areas of scientific interest to BIPI.

External Research Grants Program for U.S. Investigators

The External Research Grants Program is designed to enable research that has the potential to improve the treatment of disease, patient outcomes and the quality of healthcare. Support is awarded based on the scientific merit of each proposal received and reviewed through BIPI's External Research Grants Program processes. The External Research Grants Program is offered to all U.S. academic and community based scientists, individually or though consortia.

The External Research Grants Program allows interested investigators to submit proposals for consideration where they may independently execute research as an Investigator Initiated Study (IIS) or to work collaboratively as External Collaborative Research (ECR) to execute their research concept. BIPI does not assume regulatory responsibility for either type of external research, and thus investigators are expected to serve as Sponsor-Investigator for either IIS or ECR studies. While BIPI may consider applications for studies outside the approved indication, should such a study be approved, the investigator may have to file an IND with the FDA.

Investigator Initiated Studies (IIS) Program for U.S. Investigators
The Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) IIS Program is offered to all qualified U.S. academic and community based scientists or consortiums who are interested in independently proposing and conducting their own research. BIPI may provide drug product and/or financial support for approved IIS. BIPI does not serve as the Regulatory Sponsor for IIS.

In general, IIS are not “registrational” studies and may be “proof of concept” or “exploratory” in nature. The budget for such studies is usually less than $1 million, should reflect “fair market value” for all costs and cannot include direct salary support for the principal investigator.

External Collaborative Research Program for U.S. Investigators
BIPI’s External Collaborative Research (ECR) Program is offered to all qualified U.S. academic and community based scientists or consortiums that are interested in proposing a research study and wish to collaborate with BIPI to further develop a protocol and analyze and publish the results. In addition to providing intellectual contributions, BIPI may provide drug product and/or financial support for approved ECR. BIPI does not serve as the Regulatory Sponsor for ECR.

The preliminary budget for ECR studies should reflect “fair market value” for all costs and cannot include direct salary support for the principal investigator. Budgets for ECR will be further negotiated pending finalization of the collaborative protocol.

BIPI’s Areas of Research Interest

Cardiovascular

  • Thrombotic Disease – Investigator Initiated Studies (Open-label drug supply only requests are being considered. No financial funding is available.)
  • Thrombotic Disease – External Collaborative Research 
Oncology

Metabolism

  • Diabetes – Investigator Initiated Studies (Drug only requests are being considered. Financial funding is not being provided.)
  • Diabetes – External Collaborative Research

Respiratory

  • Asthma – External Collaborative Research
  • COPD - External Collaborative Research
  • ILD/IPF – External Collaborative Research

You can learn more about this opportunity by visiting the funder's website.

Eligibility:

  • IIS: The Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) IIS Program is offered to all qualified U.S. academic and community based scientists or consortiums who are interested in independently proposing and conducting their own research.
  • ECR: BIPI’s External Collaborative Research (ECR) Program is offered to all qualified U.S. academic and community based scientists or consortiums that are interested in proposing a research study and wish to collaborate with BIPI to further develop a protocol and analyze and publish the results.